simulx version 2023r1 (SAS institute)
SAS institute is a verified supplier 
90
Structured Review
SAS institute
simulx version 2023r1
Simulx Version 2023r1, supplied by SAS institute, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/simulx+version+2023r1/simulx+2024r1/pm40411698-69-6-10
Average 90 stars, based on 1 article reviews
Simulx Version 2023r1, supplied by SAS institute, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/simulx+version+2023r1/simulx+2024r1/pm40411698-69-6-10
Average 90 stars, based on 1 article reviews
simulx version 2023r1 - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
other:Article Title: Pharmacokinetic/Pharmacodynamic Modelling and Monte Carlo Simulations to Predict Cytomegalovirus Viral Load in Pediatric Transplant Recipients Treated with (val)Ganciclovir. Article Snippet: Monte Carlo simulations were performed using Software:Article Title: Pharmacometric Analysis to Describe Pharmacokinetics and Exposure-Efficacy Response of Ivermectin in Adolescents Infected with Trichuris trichiura. Article Snippet: The efficacy of the combination therapy of albendazole and ivermectin against Trichuris trichiura infection is higher in Tanzania than in Côte d’Ivoire.. This study therefore aimed to investigate the difference between the population pharmacokinetics (PK) at these study sites and to determine if an exposure-response analysis could explain the low efficacy of the combination therapy in Côte d’Ivoire.. Twenty-four participants (aged 12-19 years) receiving single doses of ivermectin (200 μg/kg) and albendazole (400 mg) were included in the population PK modeling. |